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More than a decade since the release of national guidelines for
establishing antimicrobial stewardship programs (ASPs), there
continues to be an emphasis on evidence-based approaches to
optimizing stewardship in the literature. The lack of strong evidence supporting antimicrobial stewardship (AS) guideline recommendations is well documented, and many stewards report
not measuring the impact of common tools such as rapid diagnostics that support many ASPs [1]. From 2010 to 2020, there
has been a nearly 3000% increase in PubMed-indexed papers
with a mention of AS (Figure 1) [2]. Efforts to bolster research
within ASPs also continues to garner attention as experts in the
field and leading infectious diseases (ID) organizations have
published recommendations or provided programming to enhance scholarly efforts [3–7].
A recent white paper released from a Society of Healthcare
Epidemiology of America working group identified 4 key research gaps in the AS literature. The most important but
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resource-intensive of these is the need for advanced study designs
and optimal analytical methods to answer questions regarding
optimal stewardship delivery and measurement of impact [4].
Over the past year, funded studies to support ID therapeutic
research and the use of advanced study designs, including randomized controlled trials, have become more common [8, 9].
Perhaps as a tangible result, leading ID journals have published
several high-impact articles focused on AS interventions. The
Southeastern Research Group Endeavor (SERGE-45) network
is one of several supporting mentored, collaborative research in
ID and AS and has methodically selected the top AS articles for
the previous 4 years [10–14]. Detailed in this article are the top
AS intervention publications from 2020 as determined by the
SERGE-45 network [8, 9, 15–25].
METHODS

Using a modified Delphi technique (detailed previously),
members of the SERGE-45 network identified AS publications
from 2020 considered to be significant using the following inclusion criteria: (1) published in 2020, including electronic,
“early-release” publications, and (2) included an actionable
intervention [26]. An actionable intervention was defined as
an AS strategy that was implemented in practice and resulted
in measurable outcomes. Clinical practice guidelines, official
statements, review articles, and articles without an actionable
intervention were excluded.
Top Stewardship Interventions 2020 • ofid • 1

Downloaded from https://academic.oup.com/ofid/article/8/9/ofab422/6350652 by guest on 25 May 2022

The number of articles related to antimicrobial stewardship published each year has increased significantly over the last decade.
Keeping up with the literature, particularly the most innovative, well-designed, or applicable to one’s own practice area, can be
challenging. The Southeastern Research Group Endeavor (SERGE-45) network reviewed antimicrobial stewardship–related, peerreviewed literature from 2020 that detailed actionable interventions. The top 13 publications were summarized following identification using a modified Delphi technique. This article highlights the selected interventions and may serve as a key resource for teaching
and training, and to identify novel or optimized stewardship opportunities within one’s institution.
Keywords. antibiotics; antimicrobial stewardship; infectious diseases; metrics; resistance.
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A PubMed search using “antimicrobial stewardship” for 2020
revealed 1501 potential publications. Abstracts were screened to
ensure that all relevant articles were considered. Seventy publications were submitted by the network for evaluation and those
meeting criteria not previously identified were also included for
consideration. A total of 121 article citations and abstracts were
distributed to the SERGE-45 network for ranking via REDCap
survey of the top 13 articles based on contribution and/or application to ASPs [27]. Follow-up email reminders were sent to
encourage participation in the voting process. Of note, no conflict of interest disclosure was required of participating voters.
Of the 84 network members at the time of survey, 30 rank
lists (36% participation) were submitted. Article ranks from the
group were averaged and the top-scoring articles were reviewed
by S. B. G., B. J. F., P. B. B., and C. M. B. via teleconference.
This group discussed rankings and settled disputes on article
rankings based on inclusion criteria and diversity of topics
included, and a final consensus on the top 13 articles was established. Included articles are presented in the discussion in
a random order and should not be considered to be ranked according to placement. Figure 2 is a flowsheet of the article selection process, and Table 1 provides a summary of the selected
articles.

A prospective observational study was conducted to evaluate
the impact of peer comparison on antibiotic prescribing by ED
physicians at patient discharge.
An ID physician presented a 30-minute educational module
on antibiotic overuse, diagnosis, and treatment of commonly
seen infections in the ED. Following the presentation, ED physicians received monthly emails with de-identified bar graphs
comparing their antibiotic prescribing to that of their peers.
Upon initiation of the peer comparison emails, prescriptions
decreased at a monthly rate of 10.4 per 1000 ED visits. The
rate of antibiotics prescribed without an indication also decreased. This study illustrates the effectiveness of de-identified
peer feedback in a new setting with unique challenges to traditional stewardship intervention implementation. There were
no Clostridioides difficile infection (CDI) tests ordered during
the 90 days after prescriptions were reviewed; readmissions
and other adverse events were not reported. Limitations to
this study include its retrospective nature and lack of control
group. Development of the educational module and scheduling
ED staff to attend may represent challenges to implementing
this type of intervention in addition to time needed to create
de-identified feedback on a monthly basis.
Multidisciplinary Penicillin Allergy Delabeling

RESULTS
Peer Comparison–Based Stewardship Intervention in the Emergency
Department

The focus of AS activities has expanded to include outpatient primary care offices and emergency departments (EDs).
Traditional inpatient stewardship strategies such as prospective
audit and feedback (PAF) are not always feasible in the ED’s fastpaced environment. Using an adapted framework based on a successful ASP in their Veterans Affairs (VA) primary care clinics
[28], Buehrle and colleagues implemented an ED ASP [15].
2 • ofid • Green et al

Many hospitals have initiated programs to evaluate medication
allergies given the abundance of data reflecting the benefits of
accurate allergy assessments [29–31]. In particular, rates of true
allergic reactions to penicillins have been shown to be far less
than previously reported [32]. Chua and colleagues conducted
a multicenter, prospective study to evaluate rate of penicillin allergy delabeling following review by trained nursing, pharmacy,
or medical staff using a validated assessment tool [16]. Based on
risk stratification, patients were directly delabeled, offered oral
penicillin challenge, or referred for outpatient allergy assessment.
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Figure 1.

2010

Articles retrieved from a PubMed
search using the term “antimicrobial
stewardship” limited to 2020
publication year
N = 1501

Articles on antimicrobial
stewardship submitted by members
of SERGE-45
N = 70

Additional articles removed for
electronic publication prior to 2020
n=3

Top-ranked articles by members of SERGE-45
selected for review
n = 13

Figure 2.

Flowchart of the database search and article selection process. Abbreviation: SERGE-45, Southeastern Research Group Endeavor.

A total of 1225 patients with 1264 reported penicillin allergies were included in the analysis. Of these, 558 (45.6%) patients were determined to be low risk. Approximately 30% of
patients were delabeled (355/1225) following the allergy assessment, the majority in the low-risk group. Estimated costs of
delabeling for the 355 patients were $6825 in the inpatient setting compared to $60 447 for the same group if referred for outpatient assessment: $21 125 for direct delabeling and $39 322
for oral challenge. Limitations included lack of diversity of patient acuity and inability to generalize across healthcare centers.
This study demonstrated efficacy and potential cost savings of
a multidisciplinary, inpatient penicillin allergy delabeling protocol without negative impact on readmission, length of stay
(LOS), or mortality.
Clinical Impact of Rapid Identification and Susceptibility Testing for GramNegative Bacteremia

Gram-negative bloodstream infections (BSIs) represent a serious infection process associated with high mortality rates
[33]. With increasing antimicrobial resistance rates, the need
for prompt, appropriate therapy is imperative [34]. Banerjee
and colleagues conducted a prospective, multicenter, randomized controlled trial assessing the clinical impact of the
Accelerate Pheno system compared to standard of care (SOC)
for patients with gram-negative bacteremia (GNB) [9]. Both

groups received PAF from the ASP, using scenario-based standardized recommendations.
In total, 497 patients were included with Escherichia coli, the
most frequently identified organism in blood cultures. The primary outcome, time to first antibiotic change from randomization, was faster in the intervention group compared to the
SOC group with a median difference of 6.3 hours (P = .02).
Similarly, time to gram-negative antibiotic change was faster
by nearly 25 hours (P < .001). Third-generation cephalosporin– and carbapenem-resistant Enterobacterales occurred
in roughly 20% and 3% of cases, respectively. Antibiotic escalations occurred 43.3 hours faster in the intervention group
compared to the SOC group (P = .01). Thirty-day mortality
occurred in 25 (11%) patients in the intervention group and 18
(8%) patients in the SOC group (P = .27). Of note, 10% of the
organisms identified were not on the Accelerate Pheno panel,
thus representing a limitation for infections caused by rare organisms. This study provides prospective data in gram-negative BSI supporting rapid diagnostics in conjunction with ASP
intervention for faster time to appropriate therapy.
Ambulatory Care Pharmacist-Led Interventions Effect on Antimicrobial
Prescribing

Approximately 30%–50% of outpatient antibiotic prescriptions are either unnecessary or inappropriate [35]. Education
Top Stewardship Interventions 2020 • ofid • 3

Downloaded from https://academic.oup.com/ofid/article/8/9/ofab422/6350652 by guest on 25 May 2022

Articles that met the inclusion criteria of actionable
antimicrobial stewardship intervention and
distributed for ranking
n = 121

alone may be an insufficient AS strategy in this setting [36].
Westerhof and colleagues evaluated the impact of a multifaceted, outpatient ASP led by 2 ambulatory care pharmacists
Table 1.
Study
Citation

(AMCPs) on prescribing practices for upper respiratory infections (URIs), urinary tract infections (UTIs), and skin and soft
tissue infections at a family medicine resident clinic [17]. The

Summary of Top 13 Antimicrobial Stewardship Intervention Publications, 2020

Study Design

Primary and Key Secondary Outcomes

Buehrle et al, Prospective, observational
2021 [15]
cohort study to evaluate
antibiotic prescribing
by ED physicians for
discharged patients and
the impact of a peercomparison stewardship intervention

Following an educational module
given by an ID physician, ED physicians were emailed antibiotic
de-identified prescribing information comparing their antibiotic prescribing to that of their peers

Primary outcomes:
- Rate of antibiotic prescriptions for patients discharged from the ED
- Overall monthly decrease of 10.4 prescriptions per 1000 ED visits
(95% CI, –21.7 to 1.0; P = .07)
- Relative decrease of 9.9 prescriptions per 1000 ED visits from
established baseline through intervention period (95% CI, –20.9 to
–1.0; P = .07).
- Random review found rate of unnecessary antibiotic prescriptions
to be 55.6% preintervention and 38.7% postintervention

Chua et al, Prospective, multicenter
2020 [16]
study evaluating impact
of a detailed allergy assessment on penicillin
allergy delabeling

Detailed allergy assessment by
trained nursing, pharmacy, or medical staff in patients prospectively
identified from 21 Jan 2019 through
31 Aug 2019. Assessments included evaluation and risk stratification using the validated antibiotic
allergy assessment tool. Based on
risk stratification, patients were directly delabeled, offered direct oral
penicillin challenge, or referred for
outpatient allergy assessment

Primary outcome:
- 355/1225 (29%) had penicillin allergy delabeling
- 161/355 patients (45%) had direct delabeling (150 low-risk allergy,
11 high-risk)
- 194/355 patients (55%) had delabeling following oral penicillin challenge
- 344/558 (62%) of low-risk allergies were delabeled
Secondary outcomes:
- Increased use of penicillins, reduced cephalosporins, and reduced
restricted antibiotics (lincosamides, fluoroquinolones, vancomycin,
carbapenems, 3rd- or 4th-generation cephalosporins) in delabeled
patients posttesting
- No difference in readmission rates, LOS, or mortality between
delabeled and non-delabeled groups

Banerjee et al, Prospective, multicenter
2020 [9]
study evaluating clinical
impact of rapid identification for GNB

GNB patients randomized Oct 2017–
Oct 2018 to 2 groups: SOC culture
and antimicrobial susceptibility
testing vs rapid organism identification and phenotypic susceptibility
testing with Accelerate Pheno
system

Primary outcome:
- Median time (hours) to first antibiotic change after randomization
was decreased by 6.3 hours in Rapid vs SOC groups (8.6, IQR
2.6–27.6 vs 14.9, IQR 3.3–41.1; P = .02)
Secondary outcomes:
- Median time (hours) to first gram-negative antibiotic change was
decreased by 24.8 hours in Rapid vs SOC groups (17.3, IQR 4.9–72
vs 42.1, IQR 10.1–72; P < .001).
- No difference in 30-d mortality, LOS, readmission, ICU LOS,
HO-CDI, or acquisition of MDRO

Westerhof Retrospective, quasiet al, 2020 experimental study in a
[17]
single family medicine
resident clinic including
adult and pediatric patients

3-pronged intervention:
1. Resident educational sessions
2. Local health system treatment
guideline pocket cards
3. Biweekly AMCP audit and feedback

Primary outcome:
- Total guideline-concordant antibiotic prescribing at baseline was
38.9% (URI, 53.3%; SSTI, 16.7%; UTI, 46.7%) and improved
across all 3 infection types to 57.9% (URI, 61.2%; SSTI, 57.6%;
UTI, 53.5%; P = .001).
Secondary outcomes:
- Significant improvements were seen in guideline-concordant antibiotic selection (68.9% vs 80.2%; P = .018), dose (76.7% vs 86.2%;
P = .023), and duration of therapy (73.3% vs 86.2%; P = .02).

Watson et al, Multicenter, quasi2020 [18]
experimental, beforeand-after intervention
study of an electronic
order set for urine
studies

An electronic order set required
providers to choose an indication
for urine studies. CDS directed
providers to order the appropriate
urine study according to the indication.

Primary outcomes:
- Number of UCs performed per 10 000 PD decreased by 40.4%
(1175.8 vs 701.4; P < .01)
- Antibiotic DOT/1000 PD for UTIs decreased by 15.2% (102.5 vs
86.9; P < .01)
- CAUTI SIR decreased from 1.0 to 0.8 (P = .21)
- Cost per 1000 PD decreased by US$2112 (P < .01), representing an
annual total estimated cost savings of US$535 181

Nace et al, Multifaceted quality im2020 [19]
provement intervention
evaluation

1-hour introductory webinar, pocketsized educational cards, tools for
system change, and educational
clinical vignettes addressing the
diagnosis and treatment of suspected uncomplicated cystitis.
Monthly web-based coaching calls
were held for staff of intervention
nursing homes.
All facilities received quarterly feedback reports regarding the management of uncomplicated cystitis.

Primary outcome:
- Lower incidence of AU for unlikely cystitis (AIRR, 0.73 [95% CI,
.59–.91]; P = .004)
Secondary outcomes:
- Lower overall AU for any UTI (AIRR, 0.83 [95% CI, .70–.99];
P = .04)
- Reduced adjusted rate of CDI (AIRR, 0.35 [95% CI, .19–.64];
P < .001)
- No difference in incidence of UCs performed, all-cause hospitalization, or death

4 • ofid • Green et al
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Table 1.

Continued

Study
Citation

Study Design

Primary and Key Secondary Outcomes

Antibiotics or no therapy for kidney
transplant recipients ≥2 months
posttransplantation with ASB

Primary outcome:
- No difference in the incidence of symptomatic UTI: 27% vs 31%;
HR 0.83 (95% CI, .50–1.40)
Secondary outcomes:
- Death: 4% vs 3%; P = NS
- Graft loss: 2% vs 3%; P = NS
- Biopsy-proven graft rejection: 3% vs 2%; P = NS
- Pyelonephritis: 17% vs 16%; P = NS
- Number of participants in whom second episode of bacteriuria
was caused by a more resistant bacteria than was their baseline
episode of ASB: 18% vs 4%; P = .003

Elligsen et al, Quasi-experimental study
2020 [8]
evaluating impact of
individualized predictive
models on antibiotic
prescribing in patients
with monomicrobial
GNB

Application of a retrospectively
derived and validated logistic
regression model was used to
predict probability of susceptibility and guide subsequent,
pharmacist-initiated antimicrobial
recommendations for a predefined cascade of antimicrobials,
from narrow to broad: ceftriaxone,
ciprofloxacin, ceftazidime,
piperacillin-tazobactam, and
meropenem/ertapenem

Primary outcomes:
- Antibiotic de-escalation: Intervention group was more likely to
have their therapy de-escalated: 29% vs 21%; aOR, 1.77 (95% CI,
1.09–2.88)
- Adequacy of therapy: No difference in the proportion of patients
who were on adequate therapy at time of culture finalization: 96%
vs 97% (P = .774)
Secondary outcomes:
- Proportion of patients on narrowest adequate therapy at time of
culture finalization: 55% vs 44%; aOR, 2.04 (95% CI, 1.27–3.27)
- Time to adequate therapy: 5 h vs 4 h (P = .95)
- Mortality: 13% vs 13% (P = .99)
- LOS: 9.7 vs 8.4 days (P = .50)
- CDI: 4% vs 3% (P = .86)
- Overall recommendation acceptance rate: 78%

Moghnieh et Single-center, retrospecal, 2020
tive interrupted time
[21]
series analysis assessing formulary restriction vs handshake
stewardship on antibiotic consumption, expenditures, nosocomial
bacteremia, and patient
outcomes

A “handshake”-based antimicrobial
stewardship program using PAF
plus education and local guideline
dissemination was compared to a
program consisting of an antimicrobial restriction policy for select
agents only

No primary endpoint was identified.
- Broad-spectrum antibiotic consumption: mean use density of
imipenem and meropenem decreased by 13.7% (P = .017) with decreased rate of prescriptions (–24.83 defined daily dose per 1000
PD per month; P = .02)
- Antibiotic expenditures: 24.6% cost reduction (P = .0001)
- Incidence of nosocomial bacteremia caused by carbapenemresistant GNB: 34.8% decrease (P = .13)
- Patient outcomes: no change was detected for all-cause mortality,
LOS, or 7-day readmissions

Claeys et al, Retrospective, quasi2021 [22]
experimental,
nonrandomized, intervention study comparing rates of urine
cultures before and
after policy intervention
for conditional urine
reflex orders

Conditional urine reflex policies were
implemented to allow for testing
based only on specific criteria met
on UA in adults admitted to acutecare beds. Three sites served as
intervention sites and 3 as control.
Two sites allowed culturing when
WBC >10 cells/HPF (restrictive
criteria) and 1 site allowed culturing when urine was positive for
leukocyte esterase, nitrites, or had
WBC >10 cells/HPF (permissive
criteria)

Primary outcome:
- Rate of UCs performed per 1000 PDs: 21% decrease in culture at
intervention site relative to control sites (P ≤ .01)
- Control
- Preintervention: 40.3 cultures/1000 PDs vs postintervention: 44.2
cultures/1000 PDs (P = .67)
- Preintervention: 35.8 cultures/1000 PDs vs postintervention: 33.7
cultures/1000 PDs (P = .29)
Secondary outcome
- Rate of GNB per 1000 PDs postintervention: 0.8 cases/1000 PDs
at intervention site vs 0.6 cases/1000 PDs at control site (P = .13)

Ridgway et
al, 2020
[23]

Intervention consisted of ASP physician performing PAF on patients
who were identified via the WISCA
tool within 24 h of antibiotic start
via page or phone call to primary
provider and via written documentation in the EMR vs control of ASP
physician–recorded antibiotic recommendations in the study base
unless regimen caused concern
for harm

Primary outcome:
- Mean hospital LOS (4.54 d vs 4.50 d; P = .6899)
Secondary outcomes:
- 30-d readmission (344 vs 374; P = .8180)
- 30-d mortality (178 vs 194; P = .8730)
- Antibiotic charges ($546.75 vs $548.72; P = .8931)
- CDI within 180 d (151 vs 165; P = .8717)
- New-onset MDRO within 180 d (55 vs 52; P = .5950)

Multicenter, randomized controlled trial
with crossover design
investigating the impact
of WISCA on patient
outcomes

Top Stewardship Interventions 2020 • ofid • 5
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Coussement Multicenter, randomized,
et al, 2021 open-label superiority
[20]
trial in kidney transplant
recipients who had ASB
and were ≥2 months
posttransplantation

Table 1.
Study
Citation

Continued
Study Design

Primary and Key Secondary Outcomes

EMR intervention was an alert that
prompted prescribers to consider
CDI test cancellation as the default
when patients were admitted >3
d and had documented laxative or
stool softener administration within
the prior 24 h

Primary outcome:
- Median (IQR) monthly rates of total monthly HO-CDI orders per
1000 PD: 10.9 (10.5–11.6) vs 7.0 (6.4–7.6); P < .001
- Rate ratio for level change in total HO-CDI testing, 0.79 (95% CI,
.73–.86)
- Median (IQR) monthly rates of inappropriate monthly HO-CDI orders per 1000 PD: 0.8 (0.8–1.0) vs 0.4 (0.3–0.6); P < .001
- Rate ratio for level change in rate of inappropriate HO-CDI testing,
0.8 (.61–1.05)
- Proportion of inappropriate tests decreased 8% to 6% (P < .001)
Secondary outcome:
- Change in rate of HO-CDI LabID events per 1000 PD before and
after: rate ratio level change, 0.74 (95% CI, .60–.91). Note: rate
decreased only in 1 of 4 hospitals

Sapozhnikov Single-center, retrospecet al, 2021 tive descriptive study
[25]
at a health system including a 604-bed academic medical center
and 2 community hospitals

The ASP team reviewed requests for
additional AST with the multidisciplinary team during microbiology
rounds. The ASP approach to AST
requests focused on decreased
treatment of culture contaminants,
recommendations for narrowspectrum, less toxic, and less
costly treatment alternatives if
appropriate. If approved by the AST
team, the requested tests were
released for viewing or performed
if not already completed.

Primary outcome:
- Of the susceptibility request (n = 67), 59.7% were from physicians
and 34.3% were from ID providers. Of the requests from ID providers 65.2% (P = .039) were approved.
- ASP pharmacist completed chart reviews for 92.5% of patients
and contacted the requester or primary team 74.6% of the time
- Interventions included approval of susceptibility in 47.8% of requests, education of providers in 43.4%, ASP referral in 7%, and
ID consult referral in 1%
- Potential benefits were prevention of unnecessary susceptibility
testing (47.8%), opportunities for providing physician education
(40.3%), discouraged treatment of contaminant (19.4%), optimized
susceptibility request (16.4%), avoided need for parenteral therapy
(10.4%), and additional workup performed (7.5%).

Abbreviations: AIRR, adjusted incidence rate ratio; AMCP, ambulatory care pharmacist; aOR, adjusted odds ratio; ASB, asymptomatic bacteriuria; ASP, antimicrobial stewardship program;
AST, antimicrobial susceptibility testing; AU, antimicrobial use; CAUTI, catheter-associated urinary tract infection; CDI, Clostridioides difficile infection; CDS, clinical decision support; CI, confidence interval; DOT, days of therapy; ED, emergency department; EMR, electronic medical record; GNB, gram-negative bacteremia; HO-CDI, hospital-onset Clostridioides difficile infection;
HPF, high-power field; HR, hazard ratio; ICU; intensive care unit; ID, infectious diseases; IQR, interquartile range; LOS, length of stay; MDRO, multidrug-resistant organism; NS, not significant; PAF, prospective audit and feedback; PD, patient-days; SIR, standardized infection ratio; SSTI, skin and soft tissue infection; SOC, standard of care; UA, urinalysis; UC, urine culture;
URI, upper respiratory infection; UTI, urinary tract infection; WBC, white blood cell; WISCA, weighted incidence syndromic combination antibiogram.

study evaluated the effect of a 3-pronged ASP intervention on
the rate of prescribing concordance with local guidelines. Based
on their previous pilot study, biweekly AMCP feedback provided positive reinforcement of prudent prescribing with constructive and supportive comments highlighting better options
when available [37].
Overall, 525 antibiotic prescriptions were audited. Guideline
concordance at baseline was 38.9% and improved across all 3
infection types to 57.9%. Improvements were most notable in
antibiotic selection, proper dose, and duration of therapy with
no significant differences by indication. This novel study provides evidence that non-ID-trained AMCPs can be effective in
ambulatory ASPs. The major limitation of the style of intervention is that it is not in “real time” and does not allow the
AMCPs to intervene on the patient case, but rather allows the
AMCP to teach and encourage change in prescribing habits
for the future.
Impact of Clinical Decision Support for Urine Studies

Integration of clinical decision support (CDS) into the electronic medical record (EMR) is recommended to help ASPs
meet targeted goals [36]. CDS may also be leveraged for diagnostic stewardship, which can improve the accuracy of
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infectious diagnoses and better inform decisions regarding
antimicrobial therapy [38]. Watson and colleagues evaluated
the impact of CDS embedded in an electronic order set intended to guide appropriate selection of urine studies [18].
The order set required providers to choose an indication for
the urine study from 3 options: (1) suspected UTI, (2) noninfectious indications, or (3) screening purposes or neutropenic patients with urinary symptoms. Specific types of urine
studies could then be ordered according to the indication. For
suspected UTI, a hard stop also required the provider to document the signs or symptoms by selecting from a list of criteria established by the Infectious Diseases Society of America
(IDSA) [39]. Urine cultures (UCs) could not be ordered for
noninfectious indications.
Following implementation of the order set, there was a significant reduction in the number of UCs performed, antibiotic
days of therapy for UTIs, and costs. A non–statistically significant reduction in the catheter-associated UTI standardized
infection ratio was also observed. Implementation of CDS for
urine studies requires adequate support from information technology resources and relies on accurate selection of the indication by the ordering clinician. Overall, this study highlights
computerized CDS as an effective tool to improve outcomes
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that align with the goals of both AS and infection prevention
programs.
A Multifaceted ASP for the Treatment of Uncomplicated Cystitis in Nursing
Home Residents

Treatment of Asymptomatic Bacteriuria in Kidney Transplant Recipients

Asymptomatic bacteriuria (ASB) is a common observation after
kidney transplantation, occurring in roughly half of recipients
[40]. Due to limited evidence in guiding management, the tendency to screen and treat ASB varies by institution and treating
clinician. A recent European survey demonstrated that >70%
of physicians always screen for ASB, and ASB is often treated
among surveyed physicians [41].
Coussement and colleagues sought to evaluate the impact of
ASB treatment on the incidence of symptomatic UTI during the
1-year transplant follow-up period [20]. There was no difference
in the cumulative incidence of symptomatic UTI between the
antibiotic and no-therapy groups. Additionally, withholding antibiotic therapy for ASB resulted in similar incidences of death,
graft loss, biopsy-proven graft rejection, pyelonephritis, and BSI
due to UTI compared to the antibiotic group. Not surprisingly,
the antibiotic group (1) developed bacteriuria caused by a more
resistant bacteria compared to the index bacteriuria episode at
a higher rate and (2) had a lower rate of ASB at 12 months post–
study inclusion, both of which were statistically significant.

Improving Decision Making in Empiric Antibiotic Selection for GNB

Selection of empiric antimicrobials requires balancing receipt of
active therapy with avoidance of unnecessarily broad-spectrum
agents [42, 43]. Tools to determine patient-specific risk for antimicrobial resistance or inadequate therapy may assist clinicians
in decision making [44–46]. Elligsen and colleagues conducted
a quasi-experimental evaluation of predictive, multivariable
models to guide AU in the treatment of GNB [8]. The intervention group received pharmacist-initiated recommendations
for patients with GNB when speciation was available with susceptibility results pending. Patients were identified via a local
stewardship database thrice daily during working hours. The
pharmacist used validated logistic regression models to recommend the lowest level of a predefined cascade of antimicrobials
while maintaining a 90% probability of susceptibility for patients with quick Sequential Organ Failure Assessment score of
3 and 80% for those with scores <3 [47, 48].
Patients in the intervention group were more likely to undergo de-escalation, primarily driven by GNB caused by E coli
and Klebsiella species. While time to adequate therapy was similar between groups, patients receiving the intervention were
more likely to be on narrowest adequate therapy at time of
culture finalization. There was no difference in mortality nor
length of stay between groups. Overall suggestion acceptance
was 78%. This study demonstrates that individualized predictive models for resistance can facilitate early de-escalation of
antimicrobials while maintaining adequate activity in patients
with GNB; however, replication of this study may be limited
by resource requirements and necessity for a high level of prescriber engagement.
Effect of Handshake Stewardship Versus Formulary Restriction

“Handshake” stewardship has been described as the use of prospective antibiotic prescription audits with rounding-based
feedback to prescribers, ideally in person, coupled with an
absence of antimicrobial restriction [49]. It is a unique ASP
strategy that accounts for the importance of human interaction and relationship building in impacting antimicrobial prescribing practices. While “handshake” stewardship appears a
promising option for ASPs, there are limited publications on the
topic and it can be resource-intensive. Moghnieh and colleagues
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UTIs are commonly diagnosed in nursing home residents. Age
and inadequate communication in this population often lead
to misdiagnosis and inappropriate antimicrobial use (AU).
Nace and colleagues conducted a multifaceted quality improvement intervention to target uncomplicated and unlikely cystitis
[19]. Unlikely cystitis was defined as asymptomatic bacteriuria,
contaminated urinary specimens, or noninfectious conditions
that can be confused with cystitis (eg, nonspecific symptoms
in the absence of urinary-specific symptoms). The intervention
nursing homes received an introductory webinar, pocket-sized
educational cards, established guidelines, and educational clinical vignettes. They also received monthly web-based coaching
calls and quarterly feedback reports for the management of uncomplicated cystitis.
At baseline, intervention facilities had higher rates of UTIs,
unlikely cystitis treated with antimicrobials, and all-cause
death at baseline; however, none were statistically significant.
Postintervention, significant reductions were observed in AU
for unlikely cystitis, overall AU for any UTI, and adjusted CDI
rates with no differences in all-cause hospitalization or death.
Limitations included lack of randomization by baseline antibiotic use and facility blinding, personnel staffing differences,
and dedicated resources for education that may not be readily
present at most institutions. However, this study provides additional support for education with feedback strategies in nursing
home settings.

Overall, a screen-and-treat strategy for ASB in kidney transplant recipients ≥1–2 months after transplantation increases
AU, promotes antimicrobial resistance, and most importantly,
does not seem to improve clinical outcomes. This study adds
important evidence and further supports the 2019 IDSA guideline recommendation against the treatment of ASB in kidney
transplant recipients >1 month posttransplantation; however,
results of this study may not be generalizable to ASB in kidney
transplant recipients during the immediate posttransplantation
period.

Evaluation of a Practice-Based Research Network Diagnostic Stewardship
Intervention

Indiscriminate ordering of UCs may lead to inappropriate ASB
treatment [50, 51]. Diagnostic stewardship may be utilized in
conjunction with AS to prevent unnecessary urine culturing
and subsequent AU [52]. Claeys and colleagues evaluated the
effectiveness of conditional urine reflex policies across hospitals
within the VA-CDC Practice-Based Research Network [22]. Six
VA sites, each with different conditional reflex policies, were
included.
There were 224573 UCs performed during the study period.
Trends in UC ordering did not differ between the pre- and
postintervention periods for either the control group or the intervention group. Restrictive reflex criteria saw the largest reduction in UC orders (21.1 cultures/1000 patient-days vs 13.1
cultures/1000 patient-days, P < .01). Nine hundred cases of BSI
were documented with no significant difference in the rate of
gram-negative BSIs at the intervention sites. The implementation of conditional reflex policies during differing years and the
variable populations between sites could have influenced the
pre- and postintervention periods, leading to the lack of significance. Despite trends not differing within intervention sites,
this study highlights a reduction in cultures between intervention and control without increasing the risk of bacteremia. With
the incorporation of separate control sites, this study provides
a unique design that emphasizes the importance of the role of
research networks in conducting meaningful multicenter comparative studies.
Weighted Incidence Syndromic Combination Antibiogram Tool

Due to antimicrobial overuse and increased resistance, it is recommended that computerized decision tools be incorporated
into ASP practices [53–56]. The weighted incidence syndromic
combination antibiogram (WISCA) was previously developed
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to assess the likelihood for appropriate coverage based on individual real-time data [23, 57]. WISCA previously showed an
increased likelihood of coverage [58], reduction in time to effective coverage, and identification of narrower choices than
previously prescribed [59, 60]. This trial investigated WISCA
impact during active ASP surveillance on LOS, mortality, readmission, adverse events, and costs. Inpatient microbiological
data were collected over a 3-year period. The ASP physician
reviewed WISCA-identified regimens that primarily included
UTI and abdominal biliary infection (ABI), with 18 and 22
combinations, respectively. However, it was prespecified that
all 6 clinical syndromes were part of the inclusion criteria,
whereas previously only UTI and ABI were of focus. It is unclear if the subgroup syndromic analysis adjusted for multiple
tests. Logistic regression models assessed regimen coverage for
isolated organisms. The ASP physician contacted the primary
provider within 24 hours of antibiotic start for intervention of
identified patients. Control group patients had recommendations recorded in the study database only, unless a concern for
harm was identified.
The enrolled 6849 patients received antibiotics for ABI
(32.33%), UTI (24.88%), community-acquired pneumonia
(CAP) (7.11%), and cellulitis (5.93%). Overall, WISCA was
not associated with improved primary and most secondary
outcomes. However, intervention for CAP diagnosis was associated with significantly decreased odds of 30-day mortality
(adjusted odds ratio, 0.582 [95% confidence interval, .396–
.854]; P = .0204), and cellulitis diagnosis was associated with
significantly shorter LOS. Of note, the previous WISCA study
discussed that certain infections may not be amenable with utilization of the WISCA tool due to syndromes, such as pneumonia, not allowing for a robust sample size. Thus, this finding
may be a chance result achieved by increased testing. However,
this study reinforces continued investigation into computerized
methods to support ASP practices.
Impact of an EMR Nudge on Reduced Testing for Hospital-Onset CDI

In 2020, ASPs continued to publish results of efforts to reduce
inappropriate testing for CDI. Howard-Anderson et al described an EMR intervention that prompted a warning screen
for prescribers to cancel CDI tests when test orders were placed
for patients admitted >3 days who had received laxatives or
stool softeners in the prior 24 hours [24]. Prescribers were able
to continue with the order if they selected a button to proceed.
This “nudge” approach was associated with decreases in both
monthly total hospital-onset CDI (HO-CDI) testing and inappropriate testing rates. In segmented regression analysis designed to control for unmeasured variables, the rate ratio for
monthly total HO-CDI orders per 1000 patient-days reflected a
21% decrease in testing for HO-CDI. The proportion of inappropriate HO-CDI tests, defined as tests ordered when a laxative or
stool softener was administered within the previous 24 hours,
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analyzed AU, cost, nosocomial bacteremia, and patient outcomes in a comparison of a formulary restriction policy versus
a “handshake” stewardship approach [21]. Practices during
the period of restriction were based upon specialist approvals
and driven by targeting broad-spectrum or expensive agents.
Practice during the “handshake” period included feedback
during daily rounds as well as education and dissemination of
local guidelines and treatment pathways of common infectious
syndromes.
The “handshake” stewardship approach was associated with
significant decreases in broad-spectrum AU and nosocomial,
carbapenem-resistant GNB. No change was detected for allcause mortality, LOS, or 7-day readmission. For facilities that
have the resources to support it, a “handshake” stewardship
approach may have positive effects on broad-spectrum antibiotic consumption and expenditures without impacting patient
outcomes.

also decreased significantly. The rate of inappropriate testing
continued to decrease each month during the postintervention
period, but implementation was not associated with an immediate level change. ASPs may consider this strategy to address
testing in the HO-CDI population when other explanations for
diarrhea exist.
Impact of an ASP Pharmacist During Microbiology Rounds

DISCUSSION

ASPs continue to mature within traditional inpatient settings
and expand into a number of outpatient settings, both for general
and specialized populations. Stewardship responsibilities are
often layered upon various existing responsibilities, making
identification of best stewardship interventions paramount
to maximize benefit with limited resources. Two important
themes were identified within the 13 articles chosen for 2020:
First, a number of articles demonstrated the importance of microbiology personnel within AS practices. Microbiology input
historically has been minimal or absent within day-to-day stewardship activities at many sites despite clear recommendations
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